DeepMed Research

ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Phase 3

Completed

Conditions: Glaucoma, Open-Angle
Ocular Hypertension

Interventions: Drug: Bimatoprost SR
Drug: Timolol Vehicle (placebo)

First Posted Date: 2014-09-25

Last Posted Date: 2020-06-11

Lead Sponsor: Allergan

Target Recruit Count: 594

Registration Number: NCT02247804

Locations: 🇺🇸
Nature Coast Clinical Research, Crystal River, Florida, United States
🇺🇸
Montebello Medical Eye Center Inc., Montebello, California, United States
🇺🇸
Glaucoma Institute of Beverly Hills, Los Angeles, California, United States

and more 103 locations

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Completed

Conditions: Crow's Feet Lines
Lateral Canthal Lines

Interventions: Biological: Botulinum Toxin Type A

First Posted Date: 2014-09-25

Last Posted Date: 2019-07-05

Lead Sponsor: Allergan

Target Recruit Count: 667

Registration Number: NCT02248844

Locations: 🇰🇷
Dr. Robbin Clinic, Gangnam-gu, Seoul, Korea, Republic of

A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm

Completed

Conditions: Cervical Dystonia
Blepharospasm

Interventions: Other: No Intervention

First Posted Date: 2014-09-22

Last Posted Date: 2016-01-08

Lead Sponsor: Allergan

Target Recruit Count: 44

Registration Number: NCT02245958

BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

Phase 2

Completed

Conditions: Osteoarthritis

Interventions: Biological: onabotulinumtoxinA
Drug: Normal Saline

First Posted Date: 2014-09-03

Last Posted Date: 2017-05-31

Lead Sponsor: Allergan

Target Recruit Count: 176

Registration Number: NCT02230956

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Phase 1

Completed

Conditions: Acne Vulgaris

Interventions: Drug: tazarotene gel 0.1%
Drug: AGN-190168 Formulation 2
Drug: AGN-190168 Formulation 1
Drug: tazarotene cream 0.1%

First Posted Date: 2014-08-15

Last Posted Date: 2015-04-30

Lead Sponsor: Allergan

Target Recruit Count: 78

Registration Number: NCT02218034

Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

Phase 2

Completed

Conditions: Presbyopia

Interventions: Drug: AGN-199201
Drug: AGN-199201 Vehicle
Drug: AGN-190584

First Posted Date: 2014-07-23

Last Posted Date: 2015-12-03

Lead Sponsor: Allergan

Target Recruit Count: 65

Registration Number: NCT02197806

BOTOX® in the Treatment of Crow's Feet Lines in China

Phase 3

Completed

Conditions: Crow's Feet Lines
Lateral Canthal Lines

Interventions: Biological: botulinum toxin Type A
Drug: Normal Saline

First Posted Date: 2014-07-21

Last Posted Date: 2016-03-14

Lead Sponsor: Allergan

Target Recruit Count: 417

Registration Number: NCT02195687

Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults

Phase 4

Completed

Conditions: Migraine Disorders

Interventions: Biological: onabotulinumtoxinA
Drug: Topiramate

First Posted Date: 2014-07-16

Last Posted Date: 2018-06-07

Lead Sponsor: Allergan

Target Recruit Count: 282

Registration Number: NCT02191579

Locations: 🇺🇸
Kansas City Bone and Joint Clinic, Overland Park, Kansas, United States
🇺🇸
Newport Beach Clinical Research Associates, Inc., Newport Beach, California, United States
🇺🇸
California Headache and Balance Center, Fresno, California, United States

and more 29 locations

An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

Completed

Conditions: Macular Edema

Interventions: Drug: dexamethasone 700 ㎍ intravitreal implant

First Posted Date: 2014-07-11

Last Posted Date: 2016-06-01

Lead Sponsor: Allergan

Target Recruit Count: 200

Registration Number: NCT02188173

Locations: 🇺🇸
Raj Maturi, MD PC, Indianapolis, Indiana, United States
🇺🇸
Texas Retina Associates, Arlington, Arlington, Texas, United States
🇺🇸
Bay Area Retina Associates, Walnut Creek, California, United States

and more 15 locations

A Study of Abicipar Pegol in Patients With Diabetic Macular Edema

Phase 2

Completed

Conditions: Macular Edema

Interventions: Drug: ranibizumab
Drug: abicipar pegol
Other: sham procedure

First Posted Date: 2014-07-10

Last Posted Date: 2015-07-14

Lead Sponsor: Allergan

Target Recruit Count: 151

Registration Number: NCT02186119

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy